# ImpediMed Limited

ImpediMed Limited is an Asset Manager based in Carlsbad, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Carlsbad, United States
- **Region:** North America
- **Address:** Carlsbad, CA, United States
- **Founded:** 1987
- **Assets under management:** Undisclosed
- **Website:** www.impedimed.com
- **LinkedIn:** https://www.linkedin.com/company/impedimed

## Regulatory record

- **Reports private funds:** No

## About

ImpediMed’s bioimpedance spectroscopy (BIS) devices accurately and noninvasively aid for early detection, assessment, and intervention in chronic diseases.

## Sectors

- Digital Health
- Healthcare Services
- MedTech

## People

- Erik Anderson — Chief Executive Officer
- Erik Anderson — Board of Directors

## Questions

### Who leads ImpediMed?

Erik Anderson was appointed CEO in 2026; he also serves on the board. Previous leaders are not publicly detailed on the current website (per firm website, 2026).

### What is ImpediMed's core technology?

ImpediMed's SOZO Digital Health Platform uses bioimpedance spectroscopy (BIS) to noninvasively measure fluid status and tissue composition. It is FDA-cleared and performs a single scan at 256 frequencies to separate intra- and extracellular fluid (per firm website).

### What clinical conditions does ImpediMed address?

The company focuses on four areas: cancer survivorship (lymphedema risk up to 58% in some populations), wellness and longevity, medical weight management (GLP-1 therapy can reduce muscle mass by up to 20%), and heart failure (affecting ~64 million people globally) (per firm website, citing published references).

### Is ImpediMed a public or private company?

ImpediMed is listed on the Australian Stock Exchange (ASX) with operations in the United States, Europe, and Australia (per firm website).

### Does ImpediMed disclose its financials or AUM?

No. ImpediMed is an operating medical technology company, not an investment vehicle, and does not publicly disclose AUM or investment deployment figures.

### What are the key products of ImpediMed?

The SOZO Digital Health Platform includes three applications: L-Dex for lymphedema detection, BodyComp for fluid and tissue composition tracking, and HF-Dex for heart failure fluid management. All are FDA-cleared (per firm website).

### Where does ImpediMed operate geographically?

The company is headquartered in Carlsbad, California, with operations in the United States, Europe, and Australia (per firm website).

## Related profiles

- [NetSuite](https://altss.com/profile/netsuite)
- [Yantai Xinchao Industry](https://altss.com/profile/yantai-xinchao-industry)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/impedimed-limited

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology